Description
CJC-1295 + Ipamorelin 10mg Blend
CJC-1295 and Ipamorelin are two peptides frequently examined in laboratory research focused on growth hormone signaling and endocrine regulation. When studied together, these compounds are often used to explore how different growth hormone pathways may interact within the body.
This blend contains 5mg of CJC-1295 and 5mg of Ipamorelin, providing a total of 10mg of peptide content per vial. Researchers often investigate the combination because each peptide influences growth hormone activity through different mechanisms.
What Is the CJC-1295 + Ipamorelin Combination?
CJC-1295 and Ipamorelin belong to a category of compounds known as growth hormone secretagogues. These molecules are studied for their ability to stimulate the release of growth hormone through specific receptor pathways.
CJC-1295 works by mimicking the activity of growth hormone releasing hormone (GHRH), which signals the pituitary gland to release growth hormone. Ipamorelin, on the other hand, interacts with ghrelin receptors, another pathway that can influence growth hormone secretion.
Because these peptides activate separate receptors, researchers often study them together to examine how they may complement each other within endocrine signaling processes.
Research Areas
Scientific investigations involving this peptide combination commonly focus on areas such as:
- growth hormone signaling and endocrine function
- metabolic regulation and nutrient utilization
- muscle recovery and tissue repair processes
- cellular regeneration pathways
- body composition research models
These studies aim to better understand how growth hormone influences metabolic activity, tissue recovery, and overall physiological regulation.
CJC-1295 in Research
CJC-1295 is a synthetic analog of growth hormone releasing hormone. It is designed to stimulate the pituitary gland to release growth hormone over an extended period.
In experimental research, CJC-1295 has been examined for its ability to increase circulating growth hormone levels by interacting with GHRH receptors. This property has made it an important peptide for studying long-acting growth hormone stimulation.
Ipamorelin in Research
Ipamorelin is a selective ghrelin receptor agonist that has been widely studied for its ability to trigger growth hormone release with relatively minimal interaction with other hormonal pathways.
Because of its receptor selectivity, researchers often examine Ipamorelin when studying targeted growth hormone stimulation and endocrine signaling.
Why Researchers Study This Blend?
Combining CJC-1295 with Ipamorelin allows scientists to investigate how two complementary growth hormone pathways may work together.
Since CJC-1295 activates GHRH receptors and Ipamorelin activates ghrelin receptors, the combination provides a useful model for examining multiple regulatory mechanisms involved in growth hormone release.
Product Specifications
Peptides: CJC-1295 + Ipamorelin
Quantity: 10mg total per vial
Composition: 5mg CJC-1295 / 5mg Ipamorelin
Form: Lyophilized powder
Purity: ≥99%
Manufactured in the USA.
Intended for laboratory research use.
Research Use Only
This compound is intended strictly for laboratory research purposes.
It is not approved for human consumption, medical treatment, or veterinary use and should only be handled in controlled research environments.
